Welcome to LookChem.com Sign In|Join Free

CAS

  • or

66-22-8

Post Buying Request

66-22-8 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

66-22-8 Usage

Organic alkali

Uracil is an organic alkali, and is one of the four major bases in RNA. It is a major component of the pyrimidine composition in ribonucleic acid (RNA) as well as in various kinds of uridines. It can connect with ribose to generate UMP whose triphosphate compound being UTP. UTP is the precursor form of uracil in RNA biosynthesis. UTP also acts as a coenzyme to be involved in the biosynthesis of certain sugars. Uracil can block the degradation effect of tegafur, and thus increasing the concentration of fluorouracil which enhance the anti-cancer effects. Fluorouracil has similar clinical indications as uracil. It is mainly used for treating digestive cancer, breast cancer and thyroid cancer. Combination with mitomycin has a good efficacy on treating advanced gastric cancer. Laboratory synthesizes uracil through the cyclization reaction between ethyl malonyl and urea for pharmaceutical and biochemical research. Uracil has tautomerism effect: Keto (2,4-2 CPCC) enol (2,4-2-hydroxy pyrimidine) in mainly exist in the form of ketone inside biological cells. Nature uracil is presented mainly in marine organisms, particulate matter and sea lysate. It is treated as life indicator in the field of organic geochemistry. Pyrimidine refers to the hexaheterocyclic compound with two nitrogen atoms in 1,3-position of the benzene ring, and it, together with pyridazine and pyrazine, are isomers of each other. Pyrimidine has a unique UV spectrum due to the presence of conjugated double bonds in its structure. Pyrimidine has a lower basicity and a weaker lectrophilic substitution reaction than pyridine. But it is more prone to have nucleophilic substitution. Derivatives of pyrimidine are widely distributed in nature, including vitamin B1, uracil, thymine, and cytosine which all containing a pyrimidine structure.

Fluorouracil

Fluorouracil, briefly referred as FU, is currently one of the most commonly used anti-cancer drug. It is white crystals with pKa = 8.1, m.p.282~283 °C. It is slightly soluble in water (12mg/ml at 25 °C) and ethanol, but insoluble in chloroform and ether. It is easily soluble in diluted acid and alkali. It is hydrolyzed in the presence of strong base but is stable in normal saline. Due to the introduction of a strong electrically fluorine atoms, the acidity of Fu is 30 times higher than its parent, uracil. The injection of Fu usually is an aqueous solution with pH 9.0 adjusted by sodium hydroxide. It is sensitive to light and easy to crystallize when stored at low temperatures or prolonged room temperature. According to the stronger ability of tumor tissue of rats in utilizing pyrimidine than normal tissue n, in 1957, Duschinsky and Heidelbergere designed and replace the 5-hydrogen in uracil to fluorine with similar size and generated Fu, as an anti-metabolite of uracil to achieve selective anticancer effects. FU has inhibitory effects on many kinds of animal transplanted tumors such as mouse leukemia L1210, L615, and adenocarcinoma 755. Tumor cells has no cross-resistance to it and other commonly used anti-cancer drugs such as cytarabine, methotrexate, mercaptopurine, cyclophosphamide, and carmustine. FU is converted into 5-fluoro-deoxy-uridine monophosphate (FDUMP) and 5-fluorouracil nucleoside triphosphate (FUTP) in tissues. FDUMP inhibits the thymidylate synthase (TS) via forming compound with TS and 5,10-methenyltetrahydrofolate, thus resulting in a lack of intracellular thymine nucleotide and further inhibition of DNA synthesis, finally leading to cell death. On the other hand, FUTP is incorporated into RNA as the substrate of RNA polymerase substrate and affect the normal synthesis and function of RNA. In tissue culture, supplement of thymidine (TdR) can reverse the FU cytotoxicity, so that it has been realized for many years that the impact on DNA is the primary growth-inhibitory mechanism of FU. However, it was found that TdR didn’t completely reverse the cytotoxicity of FU, and the combination of FU and TdR significantly improved the FU’s incorporation into RNA and its anti-cancer effect. After culturing together of L1210 leukemia cells with 6-H3-5FU for 22 hours, it was found the existence of 80 fmol of FDUMP-TS-5,10CH2-H4 folic acid complexes in 106 cell while 400 fmol of FU bound to RNA. This emphasizes the importance of FU’s incorporation into RNA FU for its anti-tumor effect. FU is a cell cycle-specific drug which playing the significant role at S-phase. Reference: China Medical Encyclopedia Editing Committee; editor: Liang Huang; Chinese Medical Encyclopedia. The above information is edited by the lookchem of Dai Xiongfeng.

Chemical property

White or light yellow crystalline needle. Melting point 338 °C; easily soluble in water, soluble in diluted ammonia, slightly soluble in cool water, insoluble in alcohol and ether.

Uses

Different sources of media describe the Uses of 66-22-8 differently. You can refer to the following data:
1. For biochemical research, drugs synthesis; being used as pharmaceutical intermediates, also used in organic synthesis
2. Nitrogenous base on RNA nucleosides.
3. antineoplastic
4. In biochemical research.
5. Uracil (Lamivudine EP Impurity F) is a nitrogenous base on RNA nucleosides.

Production methods

It is produced through the reaction of malate, sulfuric acid and urea.

Description

Uracil is a pyrimidine base and a fundamental component of RNA where it binds to adenine via hydrogen bonds. It is converted into the nucleoside uridine through the addition of a ribose moiety, then to the nucleotide uridine monophosphate by the addition of a phosphate group.

Chemical Properties

Crystalline needles. Soluble in hot water, ammonium hydroxide, and other alkalies; insoluble in alcohol and ether.

Definition

Different sources of media describe the Definition of 66-22-8 differently. You can refer to the following data:
1. A nitrogenous base that is found in RNA, replacing the thymine of DNA. It has a pyrimidine ring structure.
2. uracil: A pyrimidine derivative andone of the major component bases ofnucleotides and the nucleic acidRNA.
3. ChEBI: A common and naturally occurring pyrimidine nucleobase in which the pyrimidine ring is substituted with two oxo groups at positions 2 and 4. Found in RNA, it base pairs with adenine and replaces thymine during DNA transcription.

General Description

Certified pharmaceutical secondary standards for application in quality control, provide pharma laboratories and manufacturers with a convenient and cost-effective alternative to the preparation of in-house working standards. Uracil is one of the nucleotide bases of RNA. It is the precursor of DNA′s thymine. It acts like a carrier of genetic data and is hooked up with a ribose and three phosphates to form a ribonucleoside triphosphate once a human body produces nucleotides.

Safety Profile

Moderately toxic by intraperitoneal route. An experimental teratogen. Experimental reproductive effects. Questionable carcinogen with experimental tumorigenic data. Mutation data reported. When heated to decomposition it emits toxic fumes of NOx.

Purification Methods

Uracil crystallises from water (m 339-341o) and m 338o after sublimation in high vacuum. Its solubility in H2O at 20o is 1g/300mL. [Beilstein 24 H 312, 24 I 312, 24 II 169, 24 III/IV 1193.]

Check Digit Verification of cas no

The CAS Registry Mumber 66-22-8 includes 5 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 2 digits, 6 and 6 respectively; the second part has 2 digits, 2 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 66-22:
(4*6)+(3*6)+(2*2)+(1*2)=48
48 % 10 = 8
So 66-22-8 is a valid CAS Registry Number.
InChI:InChI=1/C4H4N2O2/c7-3-1-2-5-4(8)6-3/h1-2H,(H2,5,6,7,8)

66-22-8 Well-known Company Product Price

  • Brand
  • (Code)Product description
  • CAS number
  • Packaging
  • Price
  • Detail
  • TCI America

  • (U0013)  Uracil  >98.0%(HPLC)(T)

  • 66-22-8

  • 25g

  • 121.00CNY

  • Detail
  • TCI America

  • (U0013)  Uracil  >98.0%(HPLC)(T)

  • 66-22-8

  • 100g

  • 366.00CNY

  • Detail
  • TCI America

  • (U0013)  Uracil  >98.0%(HPLC)(T)

  • 66-22-8

  • 500g

  • 1,110.00CNY

  • Detail
  • Alfa Aesar

  • (A15570)  Uracil, 99+%   

  • 66-22-8

  • 50g

  • 322.0CNY

  • Detail
  • Alfa Aesar

  • (A15570)  Uracil, 99+%   

  • 66-22-8

  • 250g

  • 1141.0CNY

  • Detail
  • Alfa Aesar

  • (A15570)  Uracil, 99+%   

  • 66-22-8

  • 1000g

  • 3615.0CNY

  • Detail
  • Sigma-Aldrich

  • (PHR1581)    pharmaceutical secondary standard; traceable to USP; PhEur

  • 66-22-8

  • PHR1581-100MG

  • 791.15CNY

  • Detail
  • Sigma-Aldrich

  • (Y0000764)  Fluorouracil impurity C  European Pharmacopoeia (EP) Reference Standard

  • 66-22-8

  • Y0000764

  • 1,880.19CNY

  • Detail
  • USP

  • (1705753)  Uracil  United States Pharmacopeia (USP) Reference Standard

  • 66-22-8

  • 1705753-15MG

  • 4,647.24CNY

  • Detail

66-22-8SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 12, 2017

Revision Date: Aug 12, 2017

1.Identification

1.1 GHS Product identifier

Product name Uracil

1.2 Other means of identification

Product number -
Other names 2,4(1H,3H)-Pyrimidinedione

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:66-22-8 SDS

66-22-8Synthetic route

2-thiouracil
141-90-2

2-thiouracil

uracil
66-22-8

uracil

Conditions
ConditionsYield
With sodium hydroxide; methyloxirane In water at 20℃;100%
With dihydrogen peroxide; potassium hydroxide In ethanol at 0 - 60℃; for 4h;65.3%
With iodosylbenzene In acetone for 15h; Ambient temperature;62%
[1-(4-isopropoxypyrimidin-2-yl)piperidin-2-yl]-methanol
879499-38-4

[1-(4-isopropoxypyrimidin-2-yl)piperidin-2-yl]-methanol

uracil
66-22-8

uracil

Conditions
ConditionsYield
With hydrogenchloride In water at 90℃; for 0.333333h;100%
3-Phenyl-5,7a-dihydro-1-oxa-2,3a,5-triaza-inden-4-one
178047-66-0

3-Phenyl-5,7a-dihydro-1-oxa-2,3a,5-triaza-inden-4-one

uracil
66-22-8

uracil

Conditions
ConditionsYield
In methanol for 24h;100%
4-methylsulfanylpyrimidin-2(1H)-one
35551-31-6

4-methylsulfanylpyrimidin-2(1H)-one

uracil
66-22-8

uracil

Conditions
ConditionsYield
With ferrous(II) sulfate heptahydrate In water at 80℃; for 72h;100%
2'-deoxyuridine
951-78-0

2'-deoxyuridine

uracil
66-22-8

uracil

Conditions
ConditionsYield
With 18-crown-6 ether In dimethyl sulfoxide at 50℃; for 36h;97.3%
With Lactobacillus animalis ATCC 35046 2’-N-deoxyribosyltransferase immobilized in DEAE-Sepharose; water for 1h; Enzymatic reaction;22%
With potassium phosphate; 5'-amino-5'-deoxyuridine phosphorylase In Tris HCl buffer at 30℃; for 3h; pH=9; Kinetics; Concentration; Time; Enzymatic reaction;
uridine
58-96-8

uridine

A

α-D-ribofuranose-1-O-phosphate barium salt

α-D-ribofuranose-1-O-phosphate barium salt

B

uracil
66-22-8

uracil

Conditions
ConditionsYield
Stage #1: uridine With magnesium(II) chloride hexahydrate; recombinant E. coli uridine phosphorylase In aq. phosphate buffer at 23℃; pH=7.0;
Stage #2: With ammonium hydroxide; barium(II) acetate In aq. phosphate buffer at 4℃; pH=8.0;
A 96%
B n/a

A

α-D-arabinofuranosyl-1-phosphate barium salt

α-D-arabinofuranosyl-1-phosphate barium salt

B

uracil
66-22-8

uracil

Conditions
ConditionsYield
Stage #1: araU With magnesium(II) chloride hexahydrate; recombinant E. coli uridine phosphorylase In aq. phosphate buffer at 40℃; for 72h; pH=7.0;
Stage #2: With ammonium hydroxide; barium(II) acetate In aq. phosphate buffer at 4℃; pH=8.0;
A 96%
B n/a
methyl 3-methoxyprop-2-enoate
34846-90-7

methyl 3-methoxyprop-2-enoate

urea
57-13-6

urea

uracil
66-22-8

uracil

Conditions
ConditionsYield
Stage #1: urea With sodium methylate In 5,5-dimethyl-1,3-cyclohexadiene at 60℃; for 4h;
Stage #2: methyl 3-methoxyprop-2-enoate In 5,5-dimethyl-1,3-cyclohexadiene at 80 - 110℃; for 6h; Temperature; Time; Solvent; Reagent/catalyst;
95.2%
3',5'-di-O-acetyl-2'-deoxy-2'-<(4-methoxyphenyl)sulfonyl>uridine
139705-96-7

3',5'-di-O-acetyl-2'-deoxy-2'-<(4-methoxyphenyl)sulfonyl>uridine

A

[4-[(4-methoxyphenyl)sulfonyl]furan-2-yl]methyl acetate

[4-[(4-methoxyphenyl)sulfonyl]furan-2-yl]methyl acetate

B

uracil
66-22-8

uracil

Conditions
ConditionsYield
With N1,N1,N12,N12-tetramethyl-7,8-dihydro-6H-dipyrido[1,2-a:2,1'-c][1,4]diazepine-2,12-diamine In N,N-dimethyl-formamide at 20℃; for 0.25h; Inert atmosphere;A 95%
B n/a
5-bromouracil
51-20-7

5-bromouracil

uracil
66-22-8

uracil

Conditions
ConditionsYield
With N,N-dimethyl acetamide at 180℃; for 7h;93.8%
With isopropyl alcohol Product distribution; Mechanism; Quantum yield; Irradiation; deuterated 2-propanol solvents;
In ethanol Product distribution; Quantum yield; Mechanism; Irradiation; further solvent;
ethyl 3-ethoxyacrylate
1001-26-9

ethyl 3-ethoxyacrylate

urea
57-13-6

urea

uracil
66-22-8

uracil

Conditions
ConditionsYield
Stage #1: urea With sodium methylate In 5,5-dimethyl-1,3-cyclohexadiene at 60℃; for 4h;
Stage #2: ethyl 3-ethoxyacrylate In 5,5-dimethyl-1,3-cyclohexadiene at 80 - 110℃; for 6h; Temperature; Time; Solvent; Reagent/catalyst;
92.4%
2'-deoxyuridine
951-78-0

2'-deoxyuridine

2-amino-6-hydroxypurine
73-40-5

2-amino-6-hydroxypurine

A

uracil
66-22-8

uracil

B

2'-deoxyguanosine
961-07-9

2'-deoxyguanosine

Conditions
ConditionsYield
With potassium dihydrogenphosphate; multimeric uridine phosphorylase-Sepabeads-PEI-DX; purine nucleoside phosphorylase-glyoxyl-agarose In water at 45℃; for 24h; pH=10;A n/a
B 92%
3-methoxyacrylic acid ethyl ester

3-methoxyacrylic acid ethyl ester

urea
57-13-6

urea

uracil
66-22-8

uracil

Conditions
ConditionsYield
Stage #1: urea With sodium methylate In 5,5-dimethyl-1,3-cyclohexadiene at 60℃; for 4h;
Stage #2: 3-methoxyacrylic acid ethyl ester In 5,5-dimethyl-1,3-cyclohexadiene at 80 - 110℃; for 6h; Temperature; Time; Solvent; Reagent/catalyst;
90.6%
5-iodo-2-methylthio-4(3H)-pyrimidinone
76510-61-7

5-iodo-2-methylthio-4(3H)-pyrimidinone

A

uracil
66-22-8

uracil

B

5-iodouracil
696-07-1

5-iodouracil

Conditions
ConditionsYield
With Oxone In 1,4-dioxane; waterA 10%
B 90%
3-ethoxyacrylic acid methyl ester
41343-59-3

3-ethoxyacrylic acid methyl ester

urea
57-13-6

urea

uracil
66-22-8

uracil

Conditions
ConditionsYield
Stage #1: urea With sodium methylate In 5,5-dimethyl-1,3-cyclohexadiene at 60℃; for 4h;
Stage #2: 3-ethoxyacrylic acid methyl ester In 5,5-dimethyl-1,3-cyclohexadiene at 80 - 110℃; for 6h; Temperature; Time; Solvent; Reagent/catalyst;
89.2%
5-iodouracil
696-07-1

5-iodouracil

uracil
66-22-8

uracil

Conditions
ConditionsYield
With 2,2'-azobis(isobutyronitrile); hypophosphorous acid; sodium hydrogencarbonate In water for 1.5h; Heating;89%
With tris-(trimethylsilyl)silane; 2-hydroxyethanethiol; 1,1'-azobis(1-cyanocyclohexanenitrile) In water at 100℃; for 4h;98 % Turnov.
With indium In water at 20℃; sonication;
2',3'-dithiouridine
156592-92-6

2',3'-dithiouridine

uracil
66-22-8

uracil

Conditions
ConditionsYield
With triethylamine In methanol for 1h; Ambient temperature;88%
N1-Iodomethyluracil
97838-62-5

N1-Iodomethyluracil

uracil
66-22-8

uracil

Conditions
ConditionsYield
With water for 0.5h; Heating;87%
methyl 3-aminoacrylate

methyl 3-aminoacrylate

urea
57-13-6

urea

uracil
66-22-8

uracil

Conditions
ConditionsYield
Stage #1: urea With sodium methylate In 5,5-dimethyl-1,3-cyclohexadiene at 80 - 110℃; for 6h;
Stage #2: methyl 3-aminoacrylate In 5,5-dimethyl-1,3-cyclohexadiene at 80 - 110℃; for 6h; Temperature; Time; Solvent; Reagent/catalyst;
85.8%
2'-azido-2'-deoxyuridine
26929-65-7

2'-azido-2'-deoxyuridine

A

uracil
66-22-8

uracil

B

1-(2-amino-2-deoxy-β-D-ribofuranosyl)uracil
26889-39-4, 56888-92-7, 68115-81-1

1-(2-amino-2-deoxy-β-D-ribofuranosyl)uracil

Conditions
ConditionsYield
With 2,2'-azobis(isobutyronitrile); tri-n-butyl-tin hydride In N,N-dimethyl acetamide; benzene for 0.5h; Heating;A 13%
B 85%
2-hydroxypyrimidine hydrochloride
38353-09-2

2-hydroxypyrimidine hydrochloride

uracil
66-22-8

uracil

Conditions
ConditionsYield
With Agrobacterium sp. DSM 6136 for 15h;85%
2'-deoxyuridine
951-78-0

2'-deoxyuridine

Allopurinol
68-94-0

Allopurinol

A

deoxyinosine
890-38-0

deoxyinosine

B

uracil
66-22-8

uracil

Conditions
ConditionsYield
With potassium dihydrogenphosphate; multimeric uridine phosphorylase-Sepabeads-PEI-DX; purine nucleoside phosphorylase-glyoxyl-agarose In water at 45℃; for 5h; pH=10; Product distribution; Further Variations:; pH-values; Temperatures;A 85%
B n/a
C4H6N3O4S(1-)*Na(1+)

C4H6N3O4S(1-)*Na(1+)

uracil
66-22-8

uracil

Conditions
ConditionsYield
With hydrogenchloride In water at 22 - 98℃; for 5.5h; Temperature; Large scale;84.5%
ethyl 3-aminoacrylate
77570-30-0

ethyl 3-aminoacrylate

urea
57-13-6

urea

uracil
66-22-8

uracil

Conditions
ConditionsYield
Stage #1: urea With sodium methylate In 5,5-dimethyl-1,3-cyclohexadiene at 60℃; for 4h;
Stage #2: ethyl 3-aminoacrylate In 5,5-dimethyl-1,3-cyclohexadiene at 80 - 110℃; for 6h; Temperature; Time; Solvent; Reagent/catalyst;
83.4%
1,3-dibenzyluracil
34001-56-4

1,3-dibenzyluracil

uracil
66-22-8

uracil

Conditions
ConditionsYield
With ammonium formate; palladium on activated charcoal In methanol for 48h; Heating;82.5%
With boron tribromide In xylene at 138℃; for 19h;80%
With boron tribromide In xylene for 19h; Mechanism; Product distribution; Heating; various solvents, temperatures and reaction times;
n-butyl 3-n-butoxyacrylate

n-butyl 3-n-butoxyacrylate

urea
57-13-6

urea

uracil
66-22-8

uracil

Conditions
ConditionsYield
Stage #1: urea With sodium methylate In 5,5-dimethyl-1,3-cyclohexadiene at 60℃; for 4h;
Stage #2: n-butyl 3-n-butoxyacrylate In 5,5-dimethyl-1,3-cyclohexadiene at 80 - 110℃; for 6h; Temperature; Time; Solvent; Reagent/catalyst;
81.1%
2,5-diphenylpyrimido<1,2-f>-1,3,4,6-thiatriazepin-7-one
74415-65-9

2,5-diphenylpyrimido<1,2-f>-1,3,4,6-thiatriazepin-7-one

A

diphenyl-[1,3,4]thiadiazole
1456-21-9

diphenyl-[1,3,4]thiadiazole

B

uracil
66-22-8

uracil

Conditions
ConditionsYield
With hydrogenchloride In methanol for 1h; Product distribution; Heating; various thitriazepines, hydrolysis;A 64%
B 81%
4-(3-cyanopropyloxy)-2-ethoxypyrimidine

4-(3-cyanopropyloxy)-2-ethoxypyrimidine

uracil
66-22-8

uracil

Conditions
ConditionsYield
With hydrogenchloride In tetrahydrofuran for 2h; Heating;81%
2,4-dithiouracil
2001-93-6

2,4-dithiouracil

uracil
66-22-8

uracil

Conditions
ConditionsYield
With potassium superoxide; 18-crown-6 ether for 72h; Ambient temperature;80%
With diphenylselenoxide In ethanol
1-acetoxymethyluracil

1-acetoxymethyluracil

uracil
66-22-8

uracil

Conditions
ConditionsYield
With hydrogenchloride for 1h; Heating;80%
formaldehyd
50-00-0

formaldehyd

uracil
66-22-8

uracil

5-hydroxymethyl uracil
4433-40-3

5-hydroxymethyl uracil

Conditions
ConditionsYield
With potassium hydroxide In water at 50 - 52℃; for 68h;100%
With potassium hydroxide for 0.05h; microwave irradiation;98%
With potassium hydroxide In water at 0 - 55℃; for 36h;98%
methyl bromide
74-83-9

methyl bromide

uracil
66-22-8

uracil

1,3-dimethyluracil
874-14-6

1,3-dimethyluracil

Conditions
ConditionsYield
With sodium hydroxide; tetrabutylammomium bromide In dichloromethane at 40℃; for 3h;100%
propynoic acid methyl ester
922-67-8

propynoic acid methyl ester

uracil
66-22-8

uracil

(E)-3-[3-((E)-2-Methoxycarbonyl-vinyl)-2,6-dioxo-3,6-dihydro-2H-pyrimidin-1-yl]-acrylic acid methyl ester
287727-79-1

(E)-3-[3-((E)-2-Methoxycarbonyl-vinyl)-2,6-dioxo-3,6-dihydro-2H-pyrimidin-1-yl]-acrylic acid methyl ester

Conditions
ConditionsYield
With dmap In acetonitrile at 20℃; for 2h; hetero-Michael addition;100%
di-tert-butyl dicarbonate
24424-99-5

di-tert-butyl dicarbonate

uracil
66-22-8

uracil

tert-butyl 2,4-dioxo-1,2,3,4-tetrahydropyrimidine-1-carboxylate
402848-96-8

tert-butyl 2,4-dioxo-1,2,3,4-tetrahydropyrimidine-1-carboxylate

Conditions
ConditionsYield
Stage #1: uracil With pyridine; dmap at 20℃; for 0.5h; Inert atmosphere;
Stage #2: di-tert-butyl dicarbonate at 20℃; for 12h; Inert atmosphere;
100%
With dmap In acetonitrile at 20℃; for 4h;70%
With pyridine at 0 - 20℃; for 24h; Inert atmosphere;63.49%
With dmap In acetonitrile at 20℃; for 24h; regioselective reaction;
uracil
66-22-8

uracil

5,6-bisdeuteropyrimidin-2,4(1H,3H)-dione
24897-52-7

5,6-bisdeuteropyrimidin-2,4(1H,3H)-dione

Conditions
ConditionsYield
With hydrogen; water-d2; palladium on activated charcoal at 160℃; for 24h;100%
With water-d2; palladium on activated charcoal; hydrogen at 160℃; for 24h;100%
With palladium 10% on activated carbon; hydrogen; water-d2 at 20 - 160℃; for 24.1667h;96%
uracil
66-22-8

uracil

1,2,3,5-tetra-O-benzoyl-2-C-methyl-β-D-ribofuranose
15397-15-6

1,2,3,5-tetra-O-benzoyl-2-C-methyl-β-D-ribofuranose

1-(3,4-dibenzoyloxy-5-benzoyloxymethyl-3-methyl-tetrahydro-furan-2-yl)-1H-pyrimidine-2,4-dione

1-(3,4-dibenzoyloxy-5-benzoyloxymethyl-3-methyl-tetrahydro-furan-2-yl)-1H-pyrimidine-2,4-dione

Conditions
ConditionsYield
Stage #1: uracil With N,O-bis-(trimethylsilyl)-acetamide In acetonitrile at 90℃; for 0.75h;
Stage #2: 1,2,3,5-tetra-O-benzoyl-2-C-methyl-β-D-ribofuranose With trimethylsilyl trifluoromethanesulfonate In acetonitrile at 90℃; for 2h;
100%
uracil
66-22-8

uracil

sodium hydroxide
1310-73-2

sodium hydroxide

sodium pyrimidin-1-ide-2,4-dione
42563-71-3, 53006-96-5, 59245-40-8

sodium pyrimidin-1-ide-2,4-dione

Conditions
ConditionsYield
In ethanol; water at 20℃; for 0.25h;100%
uracil
66-22-8

uracil

5-bromouracil
51-20-7

5-bromouracil

Conditions
ConditionsYield
With 1,3-dibromo-5,5-dimethylimidazolidine-2,4-dione; acetic anhydride; acetic acid at 50℃; for 1.5h; Temperature; Reagent/catalyst;99.9%
With 1,3-dibromo-5,5-dimethylimidazolidine-2,4-dione; acetic anhydride; acetic acid at 50℃; for 1.5h; Temperature; Reagent/catalyst;99.9%
With N-Bromosuccinimide; montmorillonite K-10; tetrabutylammomium bromide for 0.0666667h; microwave irradiation;96%
benzyl chloride
100-44-7

benzyl chloride

uracil
66-22-8

uracil

1,3-dibenzyluracil
34001-56-4

1,3-dibenzyluracil

Conditions
ConditionsYield
With tetrabutyl ammonium fluoride for 6h;99%
With 18-crown-6 ether; potassium carbonate In acetonitrile at 40 - 82℃;91.5%
With sodium hydroxide; tetrabutylammomium bromide In benzene at 80℃; for 14h;90%
chloro-trimethyl-silane
75-77-4

chloro-trimethyl-silane

uracil
66-22-8

uracil

O,O'-bis-(trimethylsilyl)uracil
10457-14-4

O,O'-bis-(trimethylsilyl)uracil

Conditions
ConditionsYield
With 1,1,1,3,3,3-hexamethyl-disilazane Heating;99%
In various solvent(s) Silylation; Heating;83%
With triethylamine In 1,4-dioxane at 25℃; for 16h;54%
uracil
66-22-8

uracil

1,1,1,3,3,3-hexamethyl-disilazane
999-97-3

1,1,1,3,3,3-hexamethyl-disilazane

O,O'-bis-(trimethylsilyl)uracil
10457-14-4

O,O'-bis-(trimethylsilyl)uracil

Conditions
ConditionsYield
With chloro-trimethyl-silane for 24h; Reflux;99%
With chloro-trimethyl-silane at 150 - 170℃; for 2h;
for 16h; Heating;
uracil
66-22-8

uracil

1,2-di-O-acetyl-3,5-di-O-benzyl-4-C-fluoromethyl-D-ribofuranose
196604-56-5

1,2-di-O-acetyl-3,5-di-O-benzyl-4-C-fluoromethyl-D-ribofuranose

2'-O-acetyl-3',5'-di-O-benzyl-4'-C-fluoromethyluridine
196604-57-6

2'-O-acetyl-3',5'-di-O-benzyl-4'-C-fluoromethyluridine

Conditions
ConditionsYield
Stage #1: uracil With N,O-bis-(trimethylsilyl)-acetamide In acetonitrile at 80℃; for 0.5h; Inert atmosphere;
Stage #2: 1,2-di-O-acetyl-3,5-di-O-benzyl-4-C-fluoromethyl-D-ribofuranose With tin(IV) chloride In acetonitrile at 80℃; for 0.5h; Inert atmosphere;
99%
Stage #1: uracil With ammonium sulfate; 1,1,1,3,3,3-hexamethyl-disilazane for 3h; silylation; Heating;
Stage #2: 1,2-di-O-acetyl-3,5-di-O-benzyl-4-C-fluoromethyl-D-ribofuranose With trimethylsilyl trifluoromethanesulfonate In 1,2-dichloro-ethane at 0 - 20℃; for 2h; glycosylation;
91%
methyl 6-S-acetyl-3,4-anhydro-6-thio-1-O-trifluoromethanesulfonyl-α-D-tagatofuranoside
853017-72-8

methyl 6-S-acetyl-3,4-anhydro-6-thio-1-O-trifluoromethanesulfonyl-α-D-tagatofuranoside

uracil
66-22-8

uracil

thioacetic acid S-[4-(2,4-dioxo-3,4-dihydro-2H-pyrimidin-1-ylmethyl)-4-methoxy-3,6-dioxa-bicyclo[3.1.0]hex-2-ylmethyl] ester
853017-73-9

thioacetic acid S-[4-(2,4-dioxo-3,4-dihydro-2H-pyrimidin-1-ylmethyl)-4-methoxy-3,6-dioxa-bicyclo[3.1.0]hex-2-ylmethyl] ester

Conditions
ConditionsYield
Stage #1: uracil With chloro-trimethyl-silane; 1,1,1,3,3,3-hexamethyl-disilazane for 16h; Heating;
Stage #2: methyl 6-S-acetyl-3,4-anhydro-6-thio-1-O-trifluoromethanesulfonyl-α-D-tagatofuranoside In 1,2-dichloro-ethane at 60℃; for 48h;
99%
diphenyl diselenide
1666-13-3

diphenyl diselenide

uracil
66-22-8

uracil

5-(phenylselanyl)pyrimidine-2,4(1H,3H)-dione
70291-89-3

5-(phenylselanyl)pyrimidine-2,4(1H,3H)-dione

Conditions
ConditionsYield
With dihydrogen peroxide; sodium iodide In dimethyl sulfoxide at 50℃; for 3h; Schlenk technique;99%
With ammonium iodide In N,N-dimethyl-formamide at 50℃; for 2h; Reagent/catalyst; Solvent; Electrochemical reaction; Green chemistry;92%
With potassium iodide In dimethyl sulfoxide at 20℃; for 12h; Electrolysis; Green chemistry;92%
With dihydrogen peroxide; sodium iodide In dimethyl sulfoxide at 50℃;91%
With bis-[(trifluoroacetoxy)iodo]benzene In acetonitrile for 0.2h; Ambient temperature;81%
uracil
66-22-8

uracil

<5-2H>uracil
24897-50-5

<5-2H>uracil

Conditions
ConditionsYield
With water-d2; triethylamine at 70℃; for 288h; Inert atmosphere;99%
With water-d2 pH=8; Kinetics; aq. phosphate buffer;
dimesityl diselenide
71518-92-8

dimesityl diselenide

uracil
66-22-8

uracil

5-(mesitylselanyl)pyrimidine-2,4(1H,3H)-dione

5-(mesitylselanyl)pyrimidine-2,4(1H,3H)-dione

Conditions
ConditionsYield
With dihydrogen peroxide; sodium iodide In dimethyl sulfoxide at 50℃; for 3h; Schlenk technique;99%
With ammonium iodide In N,N-dimethyl-formamide at 50℃; for 2h; Electrochemical reaction; Green chemistry;89%
With dihydrogen peroxide; sodium iodide In dimethyl sulfoxide at 50℃;88%
With potassium iodide In dimethyl sulfoxide at 20℃; for 16h; Electrolysis; Green chemistry;82%
bis(p-chlorophenyl) diselenide
20541-49-5

bis(p-chlorophenyl) diselenide

uracil
66-22-8

uracil

5-((4-chlorophenyl)selanyl)pyrimidine-2,4(1H,3H)-dione

5-((4-chlorophenyl)selanyl)pyrimidine-2,4(1H,3H)-dione

Conditions
ConditionsYield
With dihydrogen peroxide; sodium iodide In dimethyl sulfoxide at 50℃; for 3h; Schlenk technique;99%
With dihydrogen peroxide; sodium iodide In dimethyl sulfoxide at 50℃;90%
With ammonium iodide In N,N-dimethyl-formamide at 50℃; for 2h; Electrochemical reaction; Green chemistry;88%
uracil
66-22-8

uracil

2,6-Dichloropyrimidine
3934-20-1

2,6-Dichloropyrimidine

Conditions
ConditionsYield
With trichlorophosphate at 105℃;98%
With phosgene; Triphenylphosphine oxide In nitrobenzene at -5 - 105℃; for 0.666667h; Inert atmosphere;90%
With N-ethyl-N,N-diisopropylamine; trichlorophosphate at 0 - 95℃; for 3h; Sealed tube;82%
uracil
66-22-8

uracil

5-iodouracil
696-07-1

5-iodouracil

Conditions
ConditionsYield
With Iodine monochloride In methanol at 50℃; for 4h;98%
With dmap; iodine; potassium carbonate In tetrahydrofuran for 5h;97%
With N6O17Se2(2-)*H3N*2H(1+); iodine In acetonitrile at 20℃; for 72h;95%
benzyl bromide
100-39-0

benzyl bromide

uracil
66-22-8

uracil

1,3-dibenzyluracil
34001-56-4

1,3-dibenzyluracil

Conditions
ConditionsYield
Stage #1: uracil With potassium carbonate for 1h; Milling;
Stage #2: benzyl bromide In N,N-dimethyl-formamide for 1h; Milling;
98%
Stage #1: uracil With potassium carbonate In N,N-dimethyl-formamide at 20℃; for 18h; Inert atmosphere;
Stage #2: benzyl bromide In N,N-dimethyl-formamide at 20℃; for 72h; Inert atmosphere;
93%
Stage #1: uracil With potassium carbonate In N,N-dimethyl-formamide for 18h; Inert atmosphere;
Stage #2: benzyl bromide In N,N-dimethyl-formamide for 72h; Inert atmosphere;
89%
With potassium carbonate In N,N-dimethyl-formamide for 48h; Ambient temperature;
With potassium hydroxide; tetrabutylammomium bromide 1.) 80 deg C, 2 h, 2.) 1 h; Yield given. Multistep reaction;
1-O-acetyl-2,3,5-tri-O-benzoyl-β-D-ribofuranose
6974-32-9

1-O-acetyl-2,3,5-tri-O-benzoyl-β-D-ribofuranose

uracil
66-22-8

uracil

uridine
58-96-8

uridine

Conditions
ConditionsYield
With chloro-trimethyl-silane; trimethylsilyl trifluoromethanesulfonate; 1,1,1,3,3,3-hexamethyl-disilazane In acetonitrile Substitution;98%
2,3,5-tri-O-acetyl-D-ribofuranosyl 1-(N-phenyl)-2,2,2-trifluoroacetimidate
942428-91-3

2,3,5-tri-O-acetyl-D-ribofuranosyl 1-(N-phenyl)-2,2,2-trifluoroacetimidate

uracil
66-22-8

uracil

Tri-O-acetyluridine
4105-38-8

Tri-O-acetyluridine

Conditions
ConditionsYield
Stage #1: uracil With N,O-bis-(trimethylsilyl)-acetamide In acetonitrile at 20℃; for 0.5h;
Stage #2: 2,3,5-tri-O-acetyl-D-ribofuranosyl 1-(N-phenyl)-2,2,2-trifluoroacetimidate With trimethylsilyl trifluoromethanesulfonate In 1,2-dichloro-ethane at 20℃; Further stages.;
98%
2,3,5-tri-O-benzoyl-D-ribofuranosyl(N-phenyl)trifluoroacetimidate
1055317-41-3

2,3,5-tri-O-benzoyl-D-ribofuranosyl(N-phenyl)trifluoroacetimidate

uracil
66-22-8

uracil

tribenzoyl uridine
1748-04-5

tribenzoyl uridine

Conditions
ConditionsYield
Stage #1: uracil With N,O-bis-(trimethylsilyl)-acetamide In acetonitrile at 20℃; for 0.5h;
Stage #2: 2,3,5-tri-O-benzoyl-D-ribofuranosyl(N-phenyl)trifluoroacetimidate With trimethylsilyl trifluoromethanesulfonate In 1,2-dichloro-ethane at 20℃; Further stages.;
98%
Stage #1: 2,3,5-tri-O-benzoyl-D-ribofuranosyl(N-phenyl)trifluoroacetimidate; uracil With N,O-Bis(trimethylsilyl)trifluoroacetamide In acetonitrile at 20℃; for 0.5h;
Stage #2: With trimethylsilyl trifluoromethanesulfonate In acetonitrile at 20℃;
88%
2,3,4,6-tetra-O-acetyl-D-galactosyl 1-(N-phenyl)-2,2,2-trifluoroacetimidate
942428-89-9

2,3,4,6-tetra-O-acetyl-D-galactosyl 1-(N-phenyl)-2,2,2-trifluoroacetimidate

uracil
66-22-8

uracil

1-(2’,3’,4’,6’-tetra-O-acetyl-β-D-galactopyranosyl)-uracil
23707-26-8

1-(2’,3’,4’,6’-tetra-O-acetyl-β-D-galactopyranosyl)-uracil

Conditions
ConditionsYield
Stage #1: 2,3,4,6-tetra-O-acetyl-D-galactosyl 1-(N-phenyl)-2,2,2-trifluoroacetimidate; uracil With N,O-Bis(trimethylsilyl)trifluoroacetamide In nitromethane at 20℃; for 0.5h;
Stage #2: With trimethylsilyl trifluoromethanesulfonate In nitromethane at 20℃;
98%
Ethyl bromodifluoroacetate
667-27-6

Ethyl bromodifluoroacetate

uracil
66-22-8

uracil

ethyl 2-(2,4-dioxo-1,2,3,4-tetrahydropyrimidin-5-yl)-2,2-difluoroacetate
1286792-94-6

ethyl 2-(2,4-dioxo-1,2,3,4-tetrahydropyrimidin-5-yl)-2,2-difluoroacetate

Conditions
ConditionsYield
With dipotassium hydrogenphosphate; fac-tris[2-phenylpyridinato-C2,N]iridium(III) In dimethyl sulfoxide at 20℃; for 24h; Schlenk technique; Irradiation; Inert atmosphere;98%
With tris[2-phenylpyridinato-C2,N]iridium(III); dipotassium hydrogenphosphate In dimethyl sulfoxide for 12h; Reagent/catalyst; Inert atmosphere;96%
With ferrocene; dihydrogen peroxide; dimethyl sulfoxide In water at 20℃; for 12.0417h; Inert atmosphere;58%
uracil
66-22-8

uracil

uracil-potassium

uracil-potassium

Conditions
ConditionsYield
With potassium hydroxide In water for 0.166667h;98%

66-22-8Relevant articles and documents

Two-dimensional 17O multiple quantum magic-angle spinning NMR of organic solids

Wu,Dong

, p. 9119 - 9125 (2001)

We report two-dimensional (2D) 17O multiple-quantum magic-angle spinning (MQMAS) NMR spectra for four 17O-labeled organic compounds: [17O2]-D-alanine (1), potassium hydrogen [17O4]dibenzoat

Structural Evidence for a [4Fe-5S] Intermediate in the Non-Redox Desulfuration of Thiouracil

Au?ynait?, Agota,Boll, Matthias,Fontecave, Marc,Fuchs, Jonathan,Golinelli-Pimpaneau, Béatrice,Me?kys, Rolandas,Pecqueur, Ludovic,Rutkien?, Rasa,Urbonavi?ius, Jaunius,Vaitekūnas, Justas,Zhou, Jingjing

supporting information, p. 424 - 431 (2020/11/30)

We recently discovered a [Fe-S]-containing protein with in vivo thiouracil desulfidase activity, dubbed TudS. The crystal structure of TudS refined at 1.5 ? resolution is reported; it harbors a [4Fe-4S] cluster bound by three cysteines only. Incubation of TudS crystals with 4-thiouracil trapped the cluster with a hydrosulfide ligand bound to the fourth non-protein-bonded iron, as established by the sulfur anomalous signal. This indicates that a [4Fe-5S] state of the cluster is a catalytic intermediate in the desulfuration reaction. Structural data and site-directed mutagenesis indicate that a water molecule is located next to the hydrosulfide ligand and to two catalytically important residues, Ser101 and Glu45. This information, together with modeling studies allow us to propose a mechanism for the unprecedented non-redox enzymatic desulfuration of thiouracil, in which a [4Fe-4S] cluster binds and activates the sulfur atom of the substrate.

Green preparation method of uracil

-

Paragraph 0024-0026, (2021/01/25)

The invention relates to a green preparation method of uracil, which comprises the following steps: proportionally mixing acetate, alkali and a benzene solvent in a reaction bottle to obtain a mixed solution, introducing carbon monoxide, pressurizing to generate aldehyde, adding a hydrogen chloride alcohol solution into the reaction bottle, and carrying out condensation reaction on aldehyde and the hydrogen chloride alcohol solution to obtain acetal, and adding urea into the reaction bottle, reacting acetal with urea to obtain a condensate, adding alkali into the reaction bottle, reacting alkali with the condensate to generate uracil sodium salt, adding acidic water into the reaction bottle, crystallizing, cooling, and filtering to obtain uracil. Carbon monoxide and acetate are innovatively used as raw materials, alkali such as sodium methoxide is used for one-pot catalytic synthesis of uracil, the synthesis method in the whole process is mild in condition, simple in process and high in yield and purity, the purposes of few three wastes and environmental protection are achieved, and the method has a good large-scale application prospect.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 66-22-8